These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 35817771)
1. Exosomal circWDR62 promotes temozolomide resistance and malignant progression through regulation of the miR-370-3p/MGMT axis in glioma. Geng X; Zhang Y; Lin X; Zeng Z; Hu J; Hao L; Xu J; Wang X; Wang H; Li Q Cell Death Dis; 2022 Jul; 13(7):596. PubMed ID: 35817771 [TBL] [Abstract][Full Text] [Related]
2. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma. Ding C; Yi X; Chen X; Wu Z; You H; Chen X; Zhang G; Sun Y; Bu X; Wu X; Lin Z; Gu J; Lin Y; Kang D J Exp Clin Cancer Res; 2021 May; 40(1):164. PubMed ID: 33975615 [TBL] [Abstract][Full Text] [Related]
3. Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma. Ding C; Yi X; Wu X; Bu X; Wang D; Wu Z; Zhang G; Gu J; Kang D Cancer Lett; 2020 Jun; 479():1-12. PubMed ID: 32194140 [TBL] [Abstract][Full Text] [Related]
4. Exosomal circ-HIPK3 Facilitates Tumor Progression and Temozolomide Resistance by Regulating miR-421/ Han C; Wang S; Wang H; Zhang J Cancer Biother Radiopharm; 2021 Sep; 36(7):537-548. PubMed ID: 32644821 [No Abstract] [Full Text] [Related]
5. Circ_0005198 enhances temozolomide resistance of glioma cells through miR-198/TRIM14 axis. Deng Y; Zhu H; Xiao L; Liu C; Meng X Aging (Albany NY); 2020 Dec; 13(2):2198-2211. PubMed ID: 33316781 [TBL] [Abstract][Full Text] [Related]
6. Regulation of temozolomide resistance in glioma cells via the RIP2/NF-κB/MGMT pathway. Hu YH; Jiao BH; Wang CY; Wu JL CNS Neurosci Ther; 2021 May; 27(5):552-563. PubMed ID: 33460245 [TBL] [Abstract][Full Text] [Related]
7. Lnc-TALC promotes O Wu P; Cai J; Chen Q; Han B; Meng X; Li Y; Li Z; Wang R; Lin L; Duan C; Kang C; Jiang C Nat Commun; 2019 May; 10(1):2045. PubMed ID: 31053733 [TBL] [Abstract][Full Text] [Related]
8. Hsa_circ_0110757 upregulates ITGA1 to facilitate temozolomide resistance in glioma by suppressing hsa-miR-1298-5p. Li H; Liu Q; Chen Z; Wu M; Zhang C; Su J; Li Y; Zhang C Cell Death Dis; 2021 Mar; 12(3):252. PubMed ID: 33674567 [TBL] [Abstract][Full Text] [Related]
9. Cyanidin-3-O-glucoside inhibits the β-catenin/MGMT pathway by upregulating miR-214-5p to reverse chemotherapy resistance in glioma cells. Zhou Y; Chen L; Ding D; Li Z; Cheng L; You Q; Zhang S Sci Rep; 2022 May; 12(1):7773. PubMed ID: 35545654 [TBL] [Abstract][Full Text] [Related]
10. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma. Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of hsa_circ_0000936 sensitizes resistant glioma cells to temozolomide by sponging miR-1294. Hua L; Huang L; Zhang X; Feng H J Biosci; 2020; 45():. PubMed ID: 32975228 [TBL] [Abstract][Full Text] [Related]
12. Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma. Si J; Li W; Li X; Cao L; Chen Z; Jiang Z Cancer Sci; 2021 Sep; 112(9):3491-3506. PubMed ID: 34036683 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study. Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131 [TBL] [Abstract][Full Text] [Related]
14. Exosome-Mediated Transfer of circ- Li G; Lan Q Cancer Biother Radiopharm; 2023 Feb; 38(1):62-73. PubMed ID: 34762494 [No Abstract] [Full Text] [Related]
15. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway. Yin H; Cui X Cancer Biother Radiopharm; 2021 Sep; 36(7):556-567. PubMed ID: 32833501 [No Abstract] [Full Text] [Related]
16. LncRNA UCA1/miR-182-5p/MGMT axis modulates glioma cell sensitivity to temozolomide through MGMT-related DNA damage pathways. Cheng M; Wang Q; Chen L; Zhao D; Tang J; Xu J; He Z Hum Pathol; 2022 May; 123():59-73. PubMed ID: 35219686 [TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_0043949 reinforces temozolomide resistance via upregulating oncogene ITGA1 axis in glioblastoma. Li X; Wang N; Leng H; Yuan H; Xu L Metab Brain Dis; 2022 Dec; 37(8):2979-2993. PubMed ID: 36301458 [TBL] [Abstract][Full Text] [Related]
19. Effect of IFN-beta on human glioma cell lines with temozolomide resistance. Yoshino A; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Naruse N; Sano E Int J Oncol; 2009 Jul; 35(1):139-48. PubMed ID: 19513561 [TBL] [Abstract][Full Text] [Related]
20. Delivery of MGMT mRNA to glioma cells by reactive astrocyte-derived exosomes confers a temozolomide resistance phenotype. Yu T; Wang X; Zhi T; Zhang J; Wang Y; Nie E; Zhou F; You Y; Liu N Cancer Lett; 2018 Oct; 433():210-220. PubMed ID: 30008386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]